ParisiVManniGSpadaroMet al. Correlation between morphological and functional retinal impairment in multiple sclerosis patients. Invest Ophthalmol Vis Sci1999; 40(11): 2520–2527.
2.
SotirchosESSaidhaS. OCT is an alternative to MRI for monitoring MS – YES. Multiple Sclerosis Journal2018. Epub ahead of print. DOI: 10.1177/1352458517753722.
3.
ThompsonAJBanwellBLBarkhofFet al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol2018; 17(2): 162–173.
4.
University of California, San Francisco MS-EPIC Team; CreeBAGourraudPAOksenbergJRet al. Long-term evolution of multiple sclerosis disability in the treatment era. Ann Neurol2016; 80(4): 499–510.
5.
GoodinDSRederATEbersGCet al. Survival in MS: A randomized cohort study 21 years after the start of the pivotal IFNβ-1b trial. Neurology2012; 78(17): 1315–1322.
6.
Aboulenein-DjamshidianFSebericN. OCT is an alternative to MRI for monitoring MS – No. Multiple Sclerosis Journal2018. Epub ahead of print. DOI: 10.1177/1352458518754366.
7.
SchlaegerRPapinuttoNZhuAHet al. Association between thoracic spinal cord gray matter atrophy and disability in multiple sclerosis. JAMA Neurol2015; 72(8): 897–904.